STEAP1 Knockdown Decreases the Sensitivity of Prostate Cancer Cells to Paclitaxel, Docetaxel and Cabazitaxel

The Six Transmembrane Epithelial Antigen of the Prostate 1 (STEAP1) protein has been indicated as an overexpressed oncoprotein in prostate cancer (PCa), associated with tumor progression and aggressiveness. Taxane-based antineoplastic drugs such as paclitaxel, docetaxel, or cabazitaxel, have been in...

Descripción completa

Detalles Bibliográficos
Autores principales: Rocha, Sandra M., Nascimento, Daniel, Coelho, Rafaella S., Cardoso, Ana Margarida, Passarinha, Luís A., Socorro, Sílvia, Maia, Cláudio J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095014/
https://www.ncbi.nlm.nih.gov/pubmed/37047621
http://dx.doi.org/10.3390/ijms24076643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095014/
https://www.ncbi.nlm.nih.gov/pubmed/37047621
http://dx.doi.org/10.3390/ijms24076643

Ejemplares similares